190 related articles for article (PubMed ID: 20585457)
1. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.
Fu S; Tong X; Cai C; Zhao Y; Wu Y; Li Y; Xu J; Zhang XC; Xu L; Chen W; Rao Z
PLoS One; 2010 Jun; 5(6):e11203. PubMed ID: 20585457
[TBL] [Abstract][Full Text] [Related]
2. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
Chen KH; Liu S; Bankston LA; Liddington RC; Leppla SH
J Biol Chem; 2007 Mar; 282(13):9834-9845. PubMed ID: 17251181
[TBL] [Abstract][Full Text] [Related]
3. The receptors that mediate the direct lethality of anthrax toxin.
Liu S; Zhang Y; Hoover B; Leppla SH
Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637
[TBL] [Abstract][Full Text] [Related]
4. Crystallization and preliminary X-ray analysis of the vWA domain of human anthrax toxin receptor 1.
Cai C; Zhao Y; Tong X; Fu S; Li Y; Wu Y; Li X; Lou Z
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jan; 67(Pt 1):64-7. PubMed ID: 21206026
[TBL] [Abstract][Full Text] [Related]
5. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
[TBL] [Abstract][Full Text] [Related]
6. Expression and purification of functional human anthrax toxin receptor (ATR/TEM8) binding domain from Escherichia coli.
Ding Z; Bradley KA; Amin Arnaout M; Xiong JP
Protein Expr Purif; 2006 Sep; 49(1):121-8. PubMed ID: 16798009
[TBL] [Abstract][Full Text] [Related]
7. Effects from metal ion in tumor endothelial marker 8 and anthrax protective antigen: BioLayer Interferometry experiment and molecular dynamics simulation study.
Jia Z; Ackroyd C; Han T; Agrawal V; Liu Y; Christensen K; Dominy B
J Comput Chem; 2017 Jun; 38(15):1183-1190. PubMed ID: 28437008
[TBL] [Abstract][Full Text] [Related]
8. Receptor-specific requirements for anthrax toxin delivery into cells.
Rainey GJ; Wigelsworth DJ; Ryan PL; Scobie HM; Collier RJ; Young JA
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13278-83. PubMed ID: 16141341
[TBL] [Abstract][Full Text] [Related]
9. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
Scobie HM; Rainey GJ; Bradley KA; Young JA
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348
[TBL] [Abstract][Full Text] [Related]
10. Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism.
Kintzer AF; Sterling HJ; Tang II; Williams ER; Krantz BA
PLoS One; 2010 Nov; 5(11):e13888. PubMed ID: 21079738
[TBL] [Abstract][Full Text] [Related]
11. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.
Martchenko M; Jeong SY; Cohen SN
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15583-8. PubMed ID: 20713715
[TBL] [Abstract][Full Text] [Related]
12. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.
Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532
[TBL] [Abstract][Full Text] [Related]
13. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.
Liu S; Leppla SH
J Biol Chem; 2003 Feb; 278(7):5227-34. PubMed ID: 12468536
[TBL] [Abstract][Full Text] [Related]
14. Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors.
Cai C; Che J; Xu L; Guo Q; Kong Y; Fu L; Xu J; Cheng Y; Chen W
PLoS One; 2011; 6(6):e20646. PubMed ID: 21674060
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of a complex between anthrax toxin and its host cell receptor.
Santelli E; Bankston LA; Leppla SH; Liddington RC
Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
[TBL] [Abstract][Full Text] [Related]
16. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
[TBL] [Abstract][Full Text] [Related]
17. Whole-cell voltage clamp measurements of anthrax toxin pore current.
Wolfe JT; Krantz BA; Rainey GJ; Young JA; Collier RJ
J Biol Chem; 2005 Nov; 280(47):39417-22. PubMed ID: 16183642
[TBL] [Abstract][Full Text] [Related]
18. Differential dependence on N-glycosylation of anthrax toxin receptors CMG2 and TEM8.
Friebe S; Deuquet J; van der Goot FG
PLoS One; 2015; 10(3):e0119864. PubMed ID: 25781883
[TBL] [Abstract][Full Text] [Related]
19. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton.
Werner E; Kowalczyk AP; Faundez V
J Biol Chem; 2006 Aug; 281(32):23227-36. PubMed ID: 16762926
[TBL] [Abstract][Full Text] [Related]
20. Development of receptor-based inhibitory RNA aptamers for anthrax toxin neutralization.
Lee SC; Gedi V; Ha NR; Cho JH; Park HC; Yoon MY
Int J Biol Macromol; 2015; 77():293-302. PubMed ID: 25841381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
